CG

Christopher B. Glascock

BS Baxter Biotech Technology Sarl: 2 patents #6 of 28Top 25%
BS Baxter Healthcare Sa: 2 patents #444 of 1,132Top 40%
BI Baxter International: 2 patents #873 of 2,334Top 40%
WU William Marsh Rice University: 2 patents #189 of 919Top 25%
Overall (All Time): #1,254,810 of 4,157,543Top 35%
4
Patents All Time

Issued Patents All Time

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
7211560 Reduced side-effect hemoglobin compositions Douglas L. Looker, Izydor Z. Apostol, Eric A. Brucker, Michael P. Doyle, David L. Foster +10 more 2007-05-01
7049406 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging Michael J. Weickert, Antony J. Mathews, Douglas D. Lemon, Daniel H. Doherty, John S. Olson 2006-05-23
6670323 Reduced side-effect hemoglobin compositions Douglas L. Looker, Izydor Z. Apostol, Eric A. Brucker, Michael P. Doyle, David L. Foster +10 more 2003-12-30
6455676 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging Michael J. Weickert, Antony J. Mathews, Douglas D. Lemon, Daniel H. Doherty, John S. Olson 2002-09-24